← FDA Drug Approvals (Drugs@FDA)

TRI-SPRINTEC

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 2003-12-29

Drug application

FDA Application #

ANDA075808

Application type

Abbreviated New Drug Application (Generic)

Brand name

TRI-SPRINTEC

Generic name

NORGESTIMATE AND ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORGESTIMATE

Dosage form

TABLET

Route

ORAL-28

Marketing status

Prescription

Sponsor

BARR

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2003-12-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown